switching between glp-1 agonists 📚There’s a growing trend you’re seeing for a reason: some patients are from medications to dual agonists., This isn’t about hype. It’s about physiology., 🧠 GLP-1 like Semaglutide Switching to Tirzepatide 5 mg
Description
He receives grant support from MicroVention, Medtronic, Balt, and Insera Therapeutics
The PREDIMED data is instructive: participants consuming substantial amounts of EVOO in an unrestricted-calorie context did not gain weight -- and showed slight improvements in central adiposity -- over nearly five years
Int J Mol Sci (2020) 21(9):3165
Rohmann N, Schlicht K, Geisler C, Hollstein T, Knappe C, Krause L, et al
Diabetes Care (2022) 45(Suppl 1):S12543
[28] Pratt, E., Ma, X., Liu, R., Robins, D., Haupt, A., Coskun, T.,
